PD23-01 BENIGN PROSTATIC HYPERPLASIA (BPH) SURGICAL VOLUME DURING THE COVID-19 PANDEMIC AT A SINGLE INSTITUTION

Abstract

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology IV (PD23)1 Sep 2021PD23-01 BENIGN PROSTATIC HYPERPLASIA (BPH) SURGICAL VOLUME DURING THE COVID-19 PANDEMIC AT A SINGLE INSTITUTION Thaiphi H. Luu, Natalia Hernandez, Ricardo R. Gonzalez, and Ricardo R. Gonzalez Thaiphi H. LuuThaiphi H. Luu More articles by this author , Natalia HernandezNatalia Hernandez More articles by this author , Ricardo R. GonzalezRicardo R. Gonzalez More articles by this author , and Ricardo R. GonzalezRicardo R. Gonzalez More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002016.01AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Conserving hospital resources during the COVID-19 pandemic has involved restricting nonessential care, especially when hospital capacity, staff and protective equipment was limited. Triage was required to assess severity of illness and need for intervention, particularly affecting the volume of elective procedures to treat BPH. We examined trends in BPH procedures in the office and hospital during surges in the pandemic. METHODS: We compiled monthly volumes for BPH procedures using CPT codes from March 2020 to January 2021 by full time faculty at a single 2541 bed hospital system. Prostatic transurethral resection, laser vaporization, laser enucleation, aquablation, and robotic assisted simple prostatectomy were performed in the hospital and categorized together as “BPH surgery.” In-office prostatic urethral lift (PUL) and convective water vapor energy (WAVE) were categorized as “MIST.” Percent change in case volume was calculated based on the previous 12-month average. Ureteroscopy and stent cases (“URS/stent”) were used as a control as they were more likely to be urgent. “Surges” during the pandemic were defined by county-specific metrics including hospitalization and COVID-19 positivity rates. RESULTS: During the pandemic, there was a modest decrease in BPH procedures with 582 cases, compared to 665 cases in the prior year. During the surges in 3/2020-4/2020, 7/2020, and 1/2021, the BPH surgery volume changed by -82.1%, -16.5%, and -47.5%, respectively. The MIST volume changed by -83.7%, +30.2%, and -7.7%, respectively. URS/stent cases decreased to a lesser degree than BPH procedures during the pandemic. CONCLUSIONS: During the COVID-19 pandemic, there was a slight decrease in the ability to perform surgery for BPH relative to stone cases. The trend was an adaptive response with pause in BPH surgeries during surges and an ensuing rebound. Office-based MIST procedures PUL and WAVE have been less affected compared to BPH surgeries in the hospital setting, likely resulting in conservation of hospital resources during surges. Source of Funding: None © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e420-e420 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Thaiphi H. Luu More articles by this author Natalia Hernandez More articles by this author Ricardo R. Gonzalez More articles by this author Ricardo R. Gonzalez More articles by this author Expand All Advertisement PDF downloadLoading ...